Chemoinformaics analysis of 9,12,15-Octadecatrienal
Molecular Weight | 262.437 | nRot | 13 |
Heavy Atom Molecular Weight | 232.197 | nRig | 4 |
Exact Molecular Weight | 262.23 | nRing | 0 |
Solubility: LogS | -4.374 | nHRing | 0 |
Solubility: LogP | 5.15 | No. of Aliphatic Rings | 0 |
Acid Count | 0 | No. of Aromatic Rings | 0 |
Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
Atoms Count | 49 | No. of Aliphatic Hetero Cycles | 0 |
No. of Heavy Atom | 19 | No. of Aromatic Carbocycles | 0 |
nHetero | 1 | No. of Aromatic Hetero Cycles | 0 |
nBridge Head | 0 | No. Saturated Carbocycles | 0 |
No. of Hydrogen atom | 30 | No. of Saturated Hetero Cycles | 0 |
No. of Carbon atom | 18 | No. of Saturated Rings | 0 |
No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
No. of Oxygen atom | 1 | No. of Arom Bond | 0 |
nHA | 1 | APOL | 50.8658 |
nHD | 0 | BPOL | 30.9642 |
QED | 0.234 |
Synth | 2.812 |
Natural Product Likeliness | 1.559 |
NR-PPAR-gamma | 0.306 |
Lipinski | Accepted |
Pfizer | Rejected |
GSK | Rejected |
Golden Triangle | Accepted |
Pgp-inh | 0.006 |
Pgp-sub | 0.001 |
HIA | 0.03 |
CACO-2 | -4.885 |
MDCK | 0.0000226 |
BBB | 0.003 |
PPB | 0.988571 |
VDSS | 2.076 |
FU | 0.00732179 |
CYP1A2-inh | 0.509 |
CYP1A2-sub | 0.2 |
CYP2c19-inh | 0.496 |
CYP2c19-sub | 0.055 |
CYP2c9-inh | 0.38 |
CYP2c9-sub | 0.977 |
CYP2d6-inh | 0.648 |
CYP2d6-sub | 0.871 |
CYP3a4-inh | 0.603 |
CYP3a4-sub | 0.065 |
CL | 2.861 |
T12 | 0.828 |
hERG | 0.074 |
Ames | 0.006 |
ROA | 0.001 |
SkinSen | 0.982 |
Carcinogencity | 0.085 |
EI | 0.967 |
Respiratory | 0.955 |
NR-Aromatase | 0.277 |
Antiviral | Yes |
Prediction | 0.648072 |